Ascletis Pharma files HKEX next-day return disclosing share repurchase for cancellation

PUBT · 2d ago
Ascletis Pharma files HKEX next-day return disclosing share repurchase for cancellation
  • Ascletis filed a next-day disclosure return showing a 100,000-share buyback on July 27 for cancellation, not yet cancelled.
  • Repurchase price range HKD 8.70-HKD 9.17; aggregate consideration HKD 898,390.
  • Total shares repurchased for cancellation under the mandate: 1,645,000, equal to 0.16% of issued shares at mandate approval.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascletis Pharma Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260727-12257301), on July 27, 2026, and is solely responsible for the information contained therein.